NEW YORK (GenomeWeb News) – ZyGem today announced an original equipment manufacturing deal with Saudi Diagnostics for ZyGem's DNA and RNA extraction kits.
Financial and other terms of the deal were not disclosed.
Saudi Diagnostics was established by the King Faisal Specialist Hospital & Research Centre (KFSHRC) as part of the Saudi government's efforts to develop a biotechnology sector in the Kingdom. The company serves as the hospital's commercial arm for developing and spinning out new biotech firms.
Saudi Diagnostics specializes in developing molecular genetic tests that are "unique in their relevance to Arab populations," ZyGem said in a statement, adding that Saudi Diagnostics is the first company to offer molecular diagnostics tests in the Arab Middle East that meet the quality standards of the College of American Pathologists.
Khalid Khabar, director of the program in biomolecular research at KFSHRC, said that the deal with ZyGem "will help [Saudi Diagnostics] to rapidly develop and expand its product base and provide services at the cutting edge of science and technology."